DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today announced that Dr. Thomas Tulip, Executive Vice President and Chief Business Officer, will participate at the Jeffries 2012 Global Healthcare Conference on June 4-7 at the Grand Hyatt in New York City. Dr. Tulip will provide an update of the Company and its development programs on Wednesday, June 6, 2012 at 4:30 PM EDT.
